Go Deep
Infinium Pharmachem Limited
Infinium Pharmachem Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,910 | 28.6 | 2.87 | 0.19 | 222.95 |
Infinium Pharmachem Limited Quarterly Results
| Line Item | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | 1,045,809,000.0 | 727,281,000.0 |
| Net Profit | 65,495,000.0 | 37,397,000.0 |
| EPS | 4.2 | 2.6 |
Infinium Pharmachem Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,896,316,640.0 | 1,557,092,320.0 | 1,356,588,320.0 | 1,142,248,500.0 | — |
| Net Profit | 121,501,580.0 | 81,451,070.0 | 113,022,220.0 | 94,899,280.0 | — |
| EPS | — | 5.6 | 10.6 | 6.8 | 4.4 |
Infinium Pharmachem Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,749,360,320.0 | 1,983,855,350.0 | 854,526,820.0 | 706,121,680.0 | — |
| Total Liabilities | 364,809,410.0 | 735,880,820.0 | 252,197,540.0 | 468,301,380.0 | — |
| Total Equity | 1,210,469,720.0 | 1,094,642,610.0 | 587,793,890.0 | 225,613,310.0 | — |
Infinium Pharmachem Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 17.0%Receivables 18.0%Inventory 22.3%Fixed assets (tangible) 16.4%Intangible assets 1.9%Long-term investments 16.6%Other assets 7.7%
How it's funded — Mar 2026
Short-term debt 8.7%Long-term debt 4.4%Payables 2.3%Other liabilities 5.5%Shareholders' equity 79.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 29.8 | 34.8 | 11.9 | 6.0 |
| Receivables | 31.5 | 33.7 | 20.5 | 15.4 |
| Inventory | 39.1 | 44.3 | 24.7 | 19.7 |
| Fixed assets (tangible) | 28.7 | 22.3 | 19.8 | 18.9 |
| Intangible assets | 3.4 | 3.4 | 0.0 | 0.0 |
| Long-term investments | 29.0 | 29.0 | 0.0 | 0.0 |
| Other assets | 13.5 | 30.8 | 8.6 | 10.6 |
| Liabilities & equity | ||||
| Short-term debt | 15.2 | 41.8 | 3.4 | 19.2 |
| Long-term debt | 7.6 | 10.0 | 0.6 | 0.5 |
| Payables | 4.1 | 12.4 | 4.5 | 6.8 |
| Other liabilities | 9.6 | 9.4 | 16.7 | 20.3 |
| Shareholders' equity | 138.5 | 124.8 | 60.2 | 23.8 |
| Net tangible assets | 117.7 | 106.1 | 58.8 | 22.6 |
Infinium Pharmachem Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating Activities | 337,341,590.0 | -291,430,050.0 | 49,176,640.0 | 85,896,390.0 |
| Investing Activities | -72,379,430.0 | -272,211,160.0 | -37,942,080.0 | -49,564,040.0 |
| Financing Activities | -315,557,290.0 | 792,920,710.0 | 48,084,920.0 | -31,047,540.0 |